Alex Powers

Alex, a PhD student in Chemistry, is a scientist and entrepreneur with extensive experience in computational drug discovery. As an interdisciplinary researcher at the Stanford AI Laboratory, he’s coauthored over 20 research papers and led international teams to discover new medicines and mechanisms. He is passionate about applying cutting edge AI methods to solve global health challenges. Alex graduated with a degree in Chemical Biology and minor in Computer Science from University of California, Berkeley, where he also served as the Editor-in-Chief of a scientific journal. His expertise and interests include medicinal chemistry, machine learning, graphic design, and science communication.

About Flex Therapeutics

Flex Therapeutics is building AI-powered technology to fight infectious diseases. In a world grappling with the profound impact of viral epidemics, as exemplified by COVID-19, coupled with the rising threats of antibiotic resistance, there is an urgent need for fast and scalable drug discovery for infectious diseases. Building on research at Stanford, Flex Therapeutics harnesses recent technological innovations in generative AI and combinatorial chemistry to unlock new frontiers and accelerate discovery of new medicines.